Pathophysiology and biomarkers of acute respiratory distress syndrome

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Acute respiratory distress syndrome (ARDS) is defined as an acute-onset, progressive, hypoxic condition with radiographic bilateral lung infiltration, which develops after several diseases or injuries, and is not derived from hydrostatic pulmonary edema. One specific pathological finding of ARDS is diffuse alveolar damage. In 2012, in an effort to increase diagnostic specificity, a revised definition of ARDS was published in JAMA. However, no new parameters or biomarkers were adopted by the revised definition. Discriminating between ARDS and other similar diseases is critically important; however, only a few biomarkers are currently available for diagnostic purposes. Furthermore, predicting the severity, response to therapy, or outcome of the illness is also important for developing treatment strategies for each patient. However, the PaO2/FIO2 ratio is currently the sole clinical parameter used for this purpose. In parallel with progress in understanding the pathophysiology of ARDS, various humoral factors induced by inflammation and molecules derived from activated cells or injured tissues have been shown as potential biomarkers that may be applied in clinical practice. In this review, the current understanding of the basic pathophysiology of ARDS and associated candidate biomarkers will be discussed.

Original languageEnglish
Article number32
JournalJournal of Intensive Care
Volume2
Issue number1
DOIs
Publication statusPublished - 2014 May 7

Fingerprint

Adult Respiratory Distress Syndrome
Biomarkers
Pulmonary Edema
Inflammation
Lung
Wounds and Injuries
Therapeutics

Keywords

  • Berlin definition
  • Cytokine
  • Damage-associated molecular patterns
  • IL-18
  • IL-8
  • Leptin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Pathophysiology and biomarkers of acute respiratory distress syndrome. / Fujishima, Seitaro.

In: Journal of Intensive Care, Vol. 2, No. 1, 32, 07.05.2014.

Research output: Contribution to journalReview article

@article{815edc6633f642ba9bc2d9a9af28a045,
title = "Pathophysiology and biomarkers of acute respiratory distress syndrome",
abstract = "Acute respiratory distress syndrome (ARDS) is defined as an acute-onset, progressive, hypoxic condition with radiographic bilateral lung infiltration, which develops after several diseases or injuries, and is not derived from hydrostatic pulmonary edema. One specific pathological finding of ARDS is diffuse alveolar damage. In 2012, in an effort to increase diagnostic specificity, a revised definition of ARDS was published in JAMA. However, no new parameters or biomarkers were adopted by the revised definition. Discriminating between ARDS and other similar diseases is critically important; however, only a few biomarkers are currently available for diagnostic purposes. Furthermore, predicting the severity, response to therapy, or outcome of the illness is also important for developing treatment strategies for each patient. However, the PaO2/FIO2 ratio is currently the sole clinical parameter used for this purpose. In parallel with progress in understanding the pathophysiology of ARDS, various humoral factors induced by inflammation and molecules derived from activated cells or injured tissues have been shown as potential biomarkers that may be applied in clinical practice. In this review, the current understanding of the basic pathophysiology of ARDS and associated candidate biomarkers will be discussed.",
keywords = "Berlin definition, Cytokine, Damage-associated molecular patterns, IL-18, IL-8, Leptin",
author = "Seitaro Fujishima",
year = "2014",
month = "5",
day = "7",
doi = "10.1186/2052-0492-2-32_32",
language = "English",
volume = "2",
journal = "Journal of Intensive Care",
issn = "2052-0492",
publisher = "Springer International Publishing AG",
number = "1",

}

TY - JOUR

T1 - Pathophysiology and biomarkers of acute respiratory distress syndrome

AU - Fujishima, Seitaro

PY - 2014/5/7

Y1 - 2014/5/7

N2 - Acute respiratory distress syndrome (ARDS) is defined as an acute-onset, progressive, hypoxic condition with radiographic bilateral lung infiltration, which develops after several diseases or injuries, and is not derived from hydrostatic pulmonary edema. One specific pathological finding of ARDS is diffuse alveolar damage. In 2012, in an effort to increase diagnostic specificity, a revised definition of ARDS was published in JAMA. However, no new parameters or biomarkers were adopted by the revised definition. Discriminating between ARDS and other similar diseases is critically important; however, only a few biomarkers are currently available for diagnostic purposes. Furthermore, predicting the severity, response to therapy, or outcome of the illness is also important for developing treatment strategies for each patient. However, the PaO2/FIO2 ratio is currently the sole clinical parameter used for this purpose. In parallel with progress in understanding the pathophysiology of ARDS, various humoral factors induced by inflammation and molecules derived from activated cells or injured tissues have been shown as potential biomarkers that may be applied in clinical practice. In this review, the current understanding of the basic pathophysiology of ARDS and associated candidate biomarkers will be discussed.

AB - Acute respiratory distress syndrome (ARDS) is defined as an acute-onset, progressive, hypoxic condition with radiographic bilateral lung infiltration, which develops after several diseases or injuries, and is not derived from hydrostatic pulmonary edema. One specific pathological finding of ARDS is diffuse alveolar damage. In 2012, in an effort to increase diagnostic specificity, a revised definition of ARDS was published in JAMA. However, no new parameters or biomarkers were adopted by the revised definition. Discriminating between ARDS and other similar diseases is critically important; however, only a few biomarkers are currently available for diagnostic purposes. Furthermore, predicting the severity, response to therapy, or outcome of the illness is also important for developing treatment strategies for each patient. However, the PaO2/FIO2 ratio is currently the sole clinical parameter used for this purpose. In parallel with progress in understanding the pathophysiology of ARDS, various humoral factors induced by inflammation and molecules derived from activated cells or injured tissues have been shown as potential biomarkers that may be applied in clinical practice. In this review, the current understanding of the basic pathophysiology of ARDS and associated candidate biomarkers will be discussed.

KW - Berlin definition

KW - Cytokine

KW - Damage-associated molecular patterns

KW - IL-18

KW - IL-8

KW - Leptin

UR - http://www.scopus.com/inward/record.url?scp=84979196604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979196604&partnerID=8YFLogxK

U2 - 10.1186/2052-0492-2-32_32

DO - 10.1186/2052-0492-2-32_32

M3 - Review article

AN - SCOPUS:84979196604

VL - 2

JO - Journal of Intensive Care

JF - Journal of Intensive Care

SN - 2052-0492

IS - 1

M1 - 32

ER -